The Red Line extension now carries a $5.75B price tag — raising questions about CTA debt, cost overruns, and whether the project is still worth it.

Jessie O’Malley Solis, the VTA’s director of real estate and transit-oriented development, said the South Bay transit agency paid $63.7 million for the tower at 488 South Almaden Blvd., a price that ...

CTA Construction Managers began demolition activities for the old Concord Middle School building, marking a significant milestone in the community's ongoing commitment to modernizing its educational ...

The Army will house the headquarters of a merged Futures Command and Training and Doctrine Command in Austin, Texas, and it ...

Illinois lawmakers are looking to expand sales taxes to include things such as streaming services, gym memberships, vehicle ...

Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Ital ...

Station group chief discusses the evolution and future of datacasting over ATSC 3.0 ...

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.

WELLESLEY HILLS, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, ...

R&D Expenses: Research and development expenses for the quarter ended March 31, 2025, were $10.1 million, compared to $9.7 million for the quarter ended March 31, 2024. The increase in R&D expenses ...

Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...